Stepan vs Sensient Technologies
SCL and SXT side by side. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How SCL and SXT compare
Sensient Technologies is the larger company, worth 3.4 times as much as Stepan ($5.1B against $1.5B).
On earnings, Sensient Technologies is cheaper: it trades at 29.9× trailing earnings, against 347× for Stepan.
Stepan grew revenue faster over the last twelve months (10.0% versus 9.5% for Sensient Technologies).
Sensient Technologies keeps more of each dollar of sales as profit, with a net margin of 9.7% compared with 0.17% at Stepan.
Both pay dividends: Stepan yields 2.4% and Sensient Technologies 1.0%.
Sensient Technologies scores higher on the StockData Score (14 against 7 for Stepan), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | SCL | SXT |
|---|---|---|
| Size and price | ||
| Market cap | $1.5B | $5.1B |
| Share price | $65.94 | $118.81 |
| Change, 1 year | 50.0% | 27.9% |
| Change, 5 years | −45.5% | 15.8% |
| Beta (5Y) | 0.87 | 0.83 |
| Employees | – | 4,070 |
| StockData Score | ||
| Total score | 7 | 14 (better) |
| Valuation score | 1 (better) | 0 |
| Growth score | 2 | 4 (better) |
| Performance score | 1 | 4 (better) |
| Health score | 1 | 3 (better) |
| Dividend score | 2 | 3 (better) |
| Valuation | ||
| P/E | 347× | 29.9× (better) |
| P/S | 0.6× (better) | 2.9× |
| P/B | 1.2× (better) | 3.9× |
| EV/EBITDA | 13.4× (better) | 18.3× |
| P/FCF | 329× | – |
| FCF yield | 0.30% (better) | −0.35% |
| Fair value | $56.29 | $95.56 |
| Margin of safety | −17.1% (better) | −24.3% |
| Growth | ||
| Revenue growth (TTM) | 10.0% (better) | 9.5% |
| Revenue growth, 5Y average | 4.5% (better) | 3.9% |
| Net income growth (TTM) | −90.4% | 21.7% (better) |
| EPS growth (TTM) | −90.4% | 21.4% (better) |
| EPS growth, 5Y average | −17.8% | 4.1% (better) |
| Profitability | ||
| Gross margin | 12.0% | 35.1% (better) |
| Operating margin | 0.95% | 14.5% (better) |
| Net margin | 0.17% | 9.7% (better) |
| FCF margin | 0.18% (better) | −1.0% |
| Return on equity | 0.35% | 13.7% (better) |
| Return on invested capital | 1.4% | 10.0% (better) |
| Financial health | ||
| Debt / equity | 0.52 (better) | 0.61 |
| Net debt / EBITDA | 3.53 | 2.36 (better) |
| Interest coverage | – | 8.0× |
| Current ratio | 1.32 | 3.97 (better) |
| Altman Z-score | 2.72 | 5.16 (better) |
| Piotroski F-score | 6 | 6 |
| Dividends and buybacks | ||
| Dividend yield | 2.4% (better) | 1.0% |
| Payout ratio | 830% | 41.2% |
| Years of dividend growth | 16 (better) | 0 |
| Dividend growth, 5Y average | 6.5% (better) | 1.0% |
| Shareholder yield | 2.4% (better) | 1.0% |
| Ownership | ||
| Held by institutions | 87.6% | 99.0% |
| Held by insiders | 4.8% | 26.0% |
| Insider net buying, 12 months | – | −$234M |
| Short interest, % of float | 3.1% | 3.1% |
Go deeper
- SCL stock overview
- SCL income statement
- SCL valuation and score
- SXT stock overview
- SXT income statement
- SXT valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.